Health and Healthcare
Great News for Lung Cancer Patients in Spectrum’s Phase 2 Trial
Published:
Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) announced good news for cancer patients in its midstage trial on Tuesday. The company announced that it met the prespecified primary endpoint in the Zenith20 Phase 2 clinical trial evaluating poziotinib in previously treated non-small cell lung cancer patients with HER2 exon 20 insertion mutations.
The second cohort of the Zenith20 clinical trial enrolled 90 patients. They all had failed at least one line of prior systemic therapy, with 60 patients (67%) having failed two or more prior therapies, including chemotherapy and immunotherapy.
The intent-to-treat analysis demonstrated a confirmed objective response rate of 27.8% with a 95% confidence interval ranging from an objective response rate of 18.9% to 38.2%.
Based on the pre-specified statistical hypothesis for the primary endpoint, the observed lower bound of 18.9% exceeded the prespecified lower bound of 17% in this heavily pretreated population.
The median duration of response was 5.1 months with a median follow up of 8.3 months. The disease control rate was 70% and the median progression-free survival was 5.5 months.
Note that the second cohort was designed to be a registrational study, and Spectrum Pharma is in the process of requesting a meeting with the FDA to discuss this data and plans for a New Drug Application submission.
Spectrum Pharma stock was last seen up about 15% at $3.73, in a 52-week range of $1.74 to $10.57. The consensus price target is $9.00.
24/7 Wall St.The Average American Is Losing Their Savings Every Day (Sponsor)
If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4% today, and inflation is much higher. Checking accounts are even worse.
Every day you don’t move to a high-yield savings account that beats inflation, you lose more and more value.
But there is good news. To win qualified customers, some accounts are paying 9-10x this national average. That’s an incredible way to keep your money safe, and get paid at the same time. Our top pick for high yield savings accounts includes other one time cash bonuses, and is FDIC insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes and your money could be working for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
